JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 10, 2003; DOI: 10.1124/jpet.103.058834


0022-3565/04/3082-694-704$20.00
JPET 308:694-704, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.058834v1
308/2/694    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawant, S. P.
Right arrow Articles by Mehendale, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawant, S. P.
Right arrow Articles by Mehendale, H. M.

TOXICOLOGY

Potentiation of Carbon Tetrachloride Hepatotoxicity and Lethality in Type 2 Diabetic Rats

Sharmilee P. Sawant, Ankur V. Dnyanmote, Kartik Shankar, Pallavi B. Limaye, John R. Latendresse, and Harihara M. Mehendale

Department of Toxicology, School of Pharmacy, University of Louisiana at Monroe, Monroe, Louisiana (S.P.S., A.V.D., K.S., P.B.L., H.M.M.); and Pathology Associates International, National Center for Toxicological Research, Jefferson, Arkansas (J.R.L.)

There is a need for well characterized and economical type 2 diabetic model that mimics the human disease. We have developed a type 2 diabetes rat model that closely resembles the diabetic patients and takes only 24 days to develop robust diabetes. Nonlethal doses of allyl alcohol (35 mg/kg i.p.), CCl4 (2 ml/kg i.p.), or thioacetamide (300 mg/kg i.p.) yielded 80 to 100% mortality in diabetic rats. The objective of the present study was to investigate two hypotheses: higher CCl4 bioactivation and/or inhibited compensatory tissue repair were the underlying mechanisms for increased CCl4 hepatotoxicity in diabetic rats. Diabetes was induced by feeding high fat diet followed by a single dose of streptozotocin on day 14 (45 mg/kg i.p.) and was confirmed on day 24 by hyperglycemia, normoinsulinemia, and oral glucose intolerance. Time course studies (0–96 h) of CCl4 (2 ml/kg i.p.) indicated that although initial liver injury was the same in nondiabetic and diabetic rats, it progressed only in the latter, culminating in hepatic failure, and death. Hepatomicrosomal CYP2E1 protein and activity, lipid peroxidation, glutathione, and 14CCl4 covalent binding to liver tissue were the same in both groups, suggesting that higher bioactivation-based injury is not the mechanism. Inhibited tissue repair resulted in progression of injury and death in diabetic rats, whereas in the nondiabetic rats robust tissue repair resulted in regression of injury and survival after CCl4 administration. These studies show high sensitivity of type 2 diabetes to model hepatotoxicants and suggest that CCl4 hepatotoxicity is potentiated due to inhibited tissue repair.


Received August 19, 2003; accepted October 29, 2003.

Address correspondence to: Dr. Harihara M. Mehendale, Department of Toxicology, School of Pharmacy, The University of Louisiana at Monroe, 700 University Ave., Monroe, LA 71209-0470. E-mail: mehendale{at}ulm.edu




This article has been cited by other articles:


Home page
Toxicol PatholHome page
D. A. Nugent, D. M. Smith, and H. B. Jones
A Review of Islet of Langerhans Degeneration in Rodent Models of Type 2 Diabetes
Toxicol Pathol, June 1, 2008; 36(4): 529 - 551.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. He, F. A. Simmen, H. M. Mehendale, M. J. J. Ronis, and T. M. Badger
Chronic Ethanol Intake Impairs Insulin Signaling in Rats by Disrupting Akt Association with the Cell Membrane: ROLE OF TRB3 IN INHIBITION OF Akt/PROTEIN KINASE B ACTIVATION
J. Biol. Chem., April 21, 2006; 281(16): 11126 - 11134.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. P. Sawant, A. V. Dnyanmote, M. S. Mitra, J. Chilakapati, A. Warbritton, J. R. Latendresse, and H. M. Mehendale
Protective Effect of Type 2 Diabetes on Acetaminophen-Induced Hepatotoxicity in Male Swiss-Webster Mice
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 507 - 519.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
H. M. Mehendale
Tissue Repair: An Important Determinant of Final Outcome of Toxicant-Induced Injury
Toxicol Pathol, January 1, 2005; 33(1): 41 - 51.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.